0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover2364.18%IV-336.05%PremiumJul 19, 2024Expiry Date5.78Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.2383Delta0.0702Gamma0.25Leverage Ratio-0.1817Theta-0.0006Rho-0.06Eff Leverage0.0006Vega
Lyell Immunopharma Stock Discussion
BOOM
Someone died
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%, ...
No comment yet